Federated Hermes Inc. acquired a new stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 133,189 shares of the biotechnology company’s stock, valued at approximately $1,253,000. Federated Hermes Inc. owned approximately 0.63% […]
Clearstead Advisors LLC bought a new position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,064 shares of the biotechnology company’s stock, valued at approximately $57,000. Other institutional investors and hedge funds have […]
Tang Capital Management LLC raised its holdings in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) by 45.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 200,000 shares of the biotechnology company’s stock after purchasing an additional 62,300 shares during the […]
Banque Pictet & Cie SA reduced its holdings in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) by 24.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,851 shares of the biotechnology company’s stock after selling 5,317 shares during the quarter. Banque Pictet […]